UK based Benchmark Holdings (BMK.L) challenges the status quo in aquaculture. Since 2000, BMK has consistently worked to build a technology-rich platform in the areas of genetics, advanced nutrition, animal health and knowledge services, to serve its customers, helping them to improve yield and efficiency in a sustainable way. The Company has leading positions in its core markets and established R&D, manufacturing and distribution capabilities to serve all the major aquaculture markets. BMK operates in 27 countries globally and employs 950 people.
Examine this trading opportunity and a host of other similar stocks. A single payment of £5.95 gives access to the VectorVest Risk Free 30-day trial. More here
On June 19th2018, BMK published interim results for the six months ended 31 March 2018. The Company reported a 91% increase in adjusted EBITDA to £6.3m on revenues 9% higher at £75.7m. An £8.2m loss for the same period last year turned into a £3.6m profit, driven by improved trading, a reduction in finance costs and a £9.2m tax credit resulting from a reduced deferred tax liability on intangibles from the acquisition of INVE. CEO Malcolm Pye said the results showed “good organic revenue growth and improving profitability on an adjusted basis, while we continue to invest in our pipeline of new products and infrastructure.” “The outlook for the Group is positive as the drivers for our business are stronger than ever before, with continued growth in aquaculture and increasing recognition from consumers, producers and regulators of the need for sustainable solutions to enable future growth.”Separately on Sept 10th2018 BMK announced the commencement of production of salmon eggs at its new land based breeding facility in Salten, Norway. The centre is the World’s most advanced egg facility, and increases Benchmark’s capacity by 75%.
Since the end of May 2018, BMK has consistently flagged a high Relative Value (RV) reading to VectorVest members. The RV metric is an indicator of long-term price appreciation potential, and even today continues to log BMK at 1.47, excellent on a scale of 0.0 – 2.0. Added to this the company logs a GRT (Earnings Growth Rate) of 32%, which also rates as excellent on the VectorVest stock and portfolio management system. Cautious investors may decide to look elsewhere given that BMK offers a ‘fair’ RS (Relative Safety) rating of 1.00, again on a scale of 0.00 to 2.00, but trading today at 62p, BMK still offers plenty of upside against a current VectorVest valuation of 81p.
The chart of BMK.L is shown above using weekly candlesticks. The share is undervalued and has recently broken upwards from a five-wave symmetrical triangle of two years duration. The first technical target from the triangle breakout is around 100p.
Summary: VectorVest has this week identified another niche sector operator, with leading positions in core aquaculture markets around the globe. This acquisitive operator has completed several notable acquisitions in the past few years, and significantly in the first half turned a loss into a profit on higher revenues. While the low RS metric may deter the more cautious investor, there is every sign that BMK is developing into a highly investible proposition given its global footprint, not to mention the opening of the World’s most advanced salmon egg facility and consequential increase in capacity. Coupled with the recent bullish charting signals, VectorVest recommends the stock as a buy
Dr David Paul
September 19th 2018
Readers can examine trading opportunities on this and a host of other similar stocks for a single payment of £5.95. This gives access to the VectorVest Risk Free 30-day trial, where members enjoy unlimited access to VectorVest UK & U.S., plus VectorVest University for on-demand strategies and training. Link here to view.
On VectorVest a simple search using the Unisearch tool will quickly find shares that are undervalued with good fundamentals that have just issued a Buy recommendation. This will give the active trader a short list of many high probability trading opportunities each week. Traders now have the opportunity to spend five weeks discovering VectorVest’s unique simplicity, automation and independent guidance. Just £5.95 buys a 30-day trial to enable deep exploration, or how the system can assist in smarter trading in as little as 10 minutes a day. Powerful tools. Proven strategies. Unique Perspectives.
Link here for more info and to set up a trial.
European Financial Publishing Limited T/A VectorVest UK (VectorVest) is authorised and regulated by the Financial Conduct Authority under register number 543038. You should remember that the value of investments and the income derived therefrom may fall as well as rise and you may not get back the amount that you invest. Past performance is not a reliable guide to the future. This material is directed only at persons in the UK and is not an offer or invitation to buy or sell securities. If investors are in any doubt of the suitability of an investment given their individual circumstances, they are recommended to contact an investment manager or independent financial adviser who may be able to provide tailored advice. Opinions expressed whether in general or both on the performance of individual securities and in a wider economic context represent the views of VectorVest at the time of preparation. They are subject to change and should not be interpreted as investment advice. VectorVest and connected companies, clients, directors, employees and other associates, may have a position in any security, or related financial instrument, issued by a company or organisation mentioned on this site. European Financial Publishing Limited is a company incorporated in Scotland under Company Number SC357322 with its registered address at Exchange Tower, 19 Canning Street, Edinburgh EH3 8EH. Email: support@VectorVest.com